Session » Abstracts: Infection-related Rheumatic Disease
- 4:00PM-5:30PM
-
Abstract Number: 1672
Association of COVID-19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case-Crossover Study
- 4:00PM-5:30PM
-
Abstract Number: 1670
Exacerbation of Immune-mediated Inflammatory Diseases in COVID19 Sequelae
- 4:00PM-5:30PM
-
Abstract Number: 1669
High Incidence of Immune-mediated Inflammatory Diseases in Sepsis Survivors: A Nationwide Exposed-non-exposed Epidemiological Study
- 4:00PM-5:30PM
-
Abstract Number: 1673
Immunomodulatory Treatment and Autoimmune Patient Responses to COVID-19 Booster Shots: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) Study
- 4:00PM-5:30PM
-
Abstract Number: 1674
Severe Infections in Patients with VEXAS Syndrome: A Study from the French VEXAS Group
- 4:00PM-5:30PM
-
Abstract Number: 1671
Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice